First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)
Clinical trial NCT04083534 · COMPLETED
Trial details
- NCT number
- NCT04083534
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2025-05-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.